West Pharmaceutical Services EPS - Earnings per Share 2012-2026 | WST
West Pharmaceutical Services annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- West Pharmaceutical Services EPS for the quarter ending June 30, 2026 was $2.15, a 18.13% increase year-over-year.
- West Pharmaceutical Services EPS for the twelve months ending June 30, 2026 was $7.81, a 16.92% increase year-over-year.
- West Pharmaceutical Services 2025 annual EPS was $6.79, a 1.49% increase from 2024.
- West Pharmaceutical Services 2024 annual EPS was $6.69, a 15.1% decline from 2023.
- West Pharmaceutical Services 2023 annual EPS was $7.88, a 1.94% increase from 2022.
| West Pharmaceutical Services Annual EPS | |
|---|---|
| 2025 | $6.79 |
| 2024 | $6.69 |
| 2023 | $7.88 |
| 2022 | $7.73 |
| 2021 | $8.67 |
| 2020 | $4.57 |
| 2019 | $3.21 |
| 2018 | $2.74 |
| 2017 | $1.99 |
| 2016 | $1.91 |
| 2015 | $1.30 |
| 2014 | $1.75 |
| 2013 | $1.57 |
| 2012 | $1.15 |
| 2011 | $1.08 |
| West Pharmaceutical Services Quarterly EPS | |
|---|---|
| 2026-06-30 | $2.15 |
| 2026-03-31 | $1.92 |
| 2025-12-31 | $1.82 |
| 2025-09-30 | $1.92 |
| 2025-06-30 | $1.82 |
| 2025-03-31 | $1.23 |
| 2024-12-31 | $1.78 |
| 2024-09-30 | $1.85 |
| 2024-06-30 | $1.51 |
| 2024-03-31 | $1.55 |
| 2023-12-31 | $1.83 |
| 2023-09-30 | $2.14 |
| 2023-06-30 | $2.06 |
| 2023-03-31 | $1.85 |
| 2022-12-31 | $1.37 |
| 2022-09-30 | $1.59 |
| 2022-06-30 | $2.48 |
| 2022-03-31 | $2.29 |
| 2021-12-31 | $1.90 |
| 2021-09-30 | $2.31 |
| 2021-06-30 | $2.47 |
| 2021-03-31 | $1.99 |
| 2020-12-31 | $1.28 |
| 2020-09-30 | $1.09 |
| 2020-06-30 | $1.21 |
| 2020-03-31 | $0.99 |
| 2019-12-31 | $0.85 |
| 2019-09-30 | $0.75 |
| 2019-06-30 | $0.88 |
| 2019-03-31 | $0.73 |
| 2018-12-31 | $0.68 |
| 2018-09-30 | $0.73 |
| 2018-06-30 | $0.75 |
| 2018-03-31 | $0.58 |
| 2017-12-31 | $0.00 |
| 2017-09-30 | $0.67 |
| 2017-06-30 | $0.51 |
| 2017-03-31 | $0.81 |
| 2016-12-31 | $0.51 |
| 2016-09-30 | $0.50 |
| 2016-06-30 | $0.60 |
| 2016-03-31 | $0.30 |
| 2015-12-31 | $0.45 |
| 2015-09-30 | $0.02 |
| 2015-06-30 | $0.38 |
| 2015-03-31 | $0.45 |
| 2014-12-31 | $0.42 |
| 2014-09-30 | $0.43 |
| 2014-06-30 | $0.52 |
| 2014-03-31 | $0.38 |
| 2013-12-31 | $0.32 |
| 2013-09-30 | $0.37 |
| 2013-06-30 | $0.43 |
| 2013-03-31 | $0.45 |
| 2012-12-31 | $0.31 |
| 2012-09-30 | $0.21 |
| 2012-06-30 | $0.23 |
| 2012-03-31 | $0.41 |
| 2011-12-31 | $0.27 |
| 2011-09-30 | $0.25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $25.687B | $3.074B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |